The European cell sheet-based gene therapy market is experiencing significant development. This field is driven by an increasing demand for innovative therapeutic solutions to address a wide range of genetic diseases. Successful clinical trials and regulatory approvals are fueling market momentum. A key factor contributing to this phenomenon is the